Introduction Executive Summary Hepatitis C: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Hepatitis C – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Hepatitis C companies’ collaborations, Licensing, Acquisition -Deal Value Trends Hepatitis C Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis TG-2349: Dongguan HEC TaiGen Biopharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis AT 527: Atea Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis HEC 74647PA: Sunshine Lake Pharma • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis Prophylactic HCV vaccine: GeneCure Biotechnologies • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Hepatitis C Key Companies Hepatitis C Key Products Hepatitis C- Unmet Needs Hepatitis C- Market Drivers and Barriers Hepatitis C- Future Perspectives and Conclusion Hepatitis C Analyst Views Hepatitis C Key Companies Appendix

Table 1 Total Products for Hepatitis C Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Dongguan HEC TaiGen Biopharmaceuticals • Nanjing Sanhome Pharmaceutical • PharmaEssentia • HEC Pharm • Atea Pharmaceuticals • AllaChem • HepC • Sunshine Lake Pharma • GeneCure Biotechnologies • Therapure Innovations • Adaptimmune • Orgenesis • Dekk-Tec